Posts

Welcome to the Fritsma Factor, please join our hemostasis discussions.

We hope that you've taken the opportunity to respond to our specimen integrity survey, which...
Mar 12, 2019 6:13pm
The iSPOT study links treatment outcomes for acute isechemic stroke in hyperglycemic patients with...
Mar 6, 2019 8:00am
The Heart.Org reports that the the Rivaroxaban and Apixaban reversal agent Andexxa (andexanet alpha...
Mar 6, 2019 7:54am
Our March, 2019 Quick Question consists of a Survey Monkey survey (click or tap) on specimen...
Mar 1, 2019 3:52pm
Mar 12, 2019 6:13pm
We hope that you've taken the opportunity to respond to our specimen integrity survey, which remains open for a few more days.
0 Comments
Mar 6, 2019 8:00am
The iSPOT study links treatment outcomes for acute isechemic stroke in hyperglycemic patients with markers of tissue factor pathway activation, as reported on March 5, 2019 in The Heart.org.
0 Comments
Mar 6, 2019 7:54am
The Heart.Org reports that the the Rivaroxaban and Apixaban reversal agent Andexxa (andexanet alpha) has earned conditional approval by the European Medicines Agency. Click or tap here for details.
0 Comments
Mar 1, 2019 3:52pm
Our March, 2019 Quick Question consists of a Survey Monkey survey (click or tap) on specimen integrity. Please see the entry for a full explanation.
0 Comments